Search for another bill

Search for another bill or initiative


SB 5240 - 2025-26

Concerning anaphylaxis medications in schools.

Bill status-at-a-glance

As of Monday, November 10, 2025 02:09 AM

Current version:

Substitute - SSB 5240

Current status:

SRules 3

Where is it in the process?

IntroducedIn committeeOn floorcalendarPassedchamberIn the Senate:In the House:
After passage:PassedLegislatureOn Governor'sdeskGovernoractedSession law

Bill status-at-a-glance

As of Monday, November 10, 2025 02:09 AM

Current version:

Substitute - SSB 5240

Current status:

SRules 3

Where is it in the process?

IntroducedIn committeeOn floorcalendarPassedchamber
Senate:
House:
PassedLegislatureOn Governor'sdeskGovernoractedSession law
AfterPassage:

Bill history

2025 Regular Session

In the Senate

Jan 14
First reading, referred to Early Learning & K-12 Education. (View original bill)
Jan 29
Public hearing in the Senate Committee on Early Learning & K-12 Education at 10:30 AM. (Committee materials)
Feb 11
Executive action taken in the Senate Committee on Early Learning & K-12 Education at 8:00 AM. (Committee materials)
EDU - Majority; 1st substitute bill be substituted, do pass. (View 1st substitute) (Majority report)
Feb 12
Passed to Rules Committee for second reading.
Mar 5
Placed on second reading by Rules Committee.
Mar 10
1st substitute bill substituted (EDU 25). (View 1st substitute)
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0. (View this roll call)

In the House

Mar 12
First reading, referred to Education.
Mar 18
Public hearing in the House Committee on Education at 4:00 PM. (Committee materials)
Apr 27
By resolution, returned to Senate Rules Committee for third reading.

Available documents

For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.

Fiscal note

Amendments

Available videos